Semler Scientific, Inc.

NasdaqCM:SMLR 株式レポート

時価総額:US$310.7m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Semler Scientific 将来の成長

Future 基準チェック /06

Semler Scientificの収益と利益はそれぞれ年間5.7%と187.8%減少すると予測されていますが、EPS は年間195.4% 減少すると予測されています。

主要情報

-187.8%

収益成長率

-195.44%

EPS成長率

Medical Equipment 収益成長16.2%
収益成長率-5.7%
将来の株主資本利益率n/a
アナリストカバレッジ

Low

最終更新日16 Jan 2026

今後の成長に関する最新情報

Recent updates

ナラティブの更新 Jan 25

SMLR: All Stock Strive Deal Will Unlock Bitcoin Treasury Upside

Analysts have reaffirmed their fair value estimate for Semler Scientific at US$86.00, highlighting adjusted assumptions around the discount rate, revenue trends and profit margin, along with a lower but still very large future P/E expectation as the key drivers behind holding the target steady. What's in the News Strive, Inc.
ナラティブの更新 Jan 08

SMLR: Future Profits And January Meeting Will Support Bullish Thesis

Analysts have reduced their price target on Semler Scientific from US$60.00 to US$51.00, citing softer revenue growth assumptions, a higher discount rate, and a very large future P/E multiple, even as projected profit margins edge slightly higher. What's in the News Semler Scientific has scheduled a special or extraordinary shareholders meeting for January 13, 2026, giving investors a date to watch for company level decisions or approvals that require shareholder input (Key Developments).
ナラティブの更新 Dec 18

SMLR: All Stock Acquisition Will Unlock Bitcoin Treasury Upside

Analysts have reduced their price target on Semler Scientific to $86 from $101, citing lower revenue and margin forecasts, as well as uncertainty and opportunity created by the recent all stock acquisition agreement and legal settlement. Analyst Commentary Bullish analysts acknowledge the reduced price targets but continue to frame the all stock acquisition and legal settlement as catalysts that could unlock value for Semler Scientific over the medium term.
ナラティブの更新 Dec 04

SMLR: Shares Will Rise As All Stock Acquisition Drives Bitcoin Treasury Consolidation

Analysts have trimmed their average price target for Semler Scientific by about $15 to roughly $83 per share, citing reduced revenue expectations following updated management guidance and the implications of the recent DOJ settlement. They continue to view the stock as an attractive opportunity in light of the pending all stock acquisition by Strive and consolidation prospects in the corporate bitcoin treasury space.
ナラティブの更新 Nov 20

SMLR: Shares Will Reflect Upside As $1.4 Billion Acquisition Advances

Analysts have lowered their fair value estimate for Semler Scientific by approximately $10. This change is due to reduced revenue growth projections and updated guidance in light of recent acquisition and settlement developments.
ナラティブの更新 Sep 24

Cardiac And Digital Health Expansion Will Encounter Bitcoin Risks

Analysts have lowered their price target for Semler Scientific from $85.33 to $75.33, citing reduced revenue forecasts following cautious management guidance, weighing of recent legal settlements, and uncertainty around the company’s pivot to a bitcoin treasury strategy despite some bullish views on its potential long-term re-rating. Analyst Commentary Bullish analysts see the acquisition by Strive (ASST) as triggering potential consolidation in the corporate bitcoin treasury sector, presenting a timely opportunity despite market uncertainty around the transaction’s longer-term implications.
分析記事 Aug 21

Is Semler Scientific (NASDAQ:SMLR) Using Too Much Debt?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
User avatar
新しいナラティブ Aug 10

Cardiac And Digital Health Expansion Will Encounter Bitcoin Risks

Diversification into cardiac disease markets and value-based care tools positions the company for higher recurring revenues and improved long-term margins.
分析記事 Jul 09

Semler Scientific, Inc.'s (NASDAQ:SMLR) 26% Share Price Surge Not Quite Adding Up

Semler Scientific, Inc. ( NASDAQ:SMLR ) shares have had a really impressive month, gaining 26% after a shaky period...
Seeking Alpha May 29

Semler Scientific: Not The Ideal Bitcoin Treasury Company

Summary Semler Scientific's pivot to a Bitcoin treasury strategy has been successful. However, competition in the Bitcoin Treasury company space is heating up, including many well funded competitors. Declining revenues and free cash flow in its healthcare business are concerning, and Bitcoin is materially outperforming the Company year to date. Read the full article on Seeking Alpha
分析記事 May 17

Semler Scientific, Inc.'s (NASDAQ:SMLR) 32% Price Boost Is Out Of Tune With Revenues

Semler Scientific, Inc. ( NASDAQ:SMLR ) shareholders are no doubt pleased to see that the share price has bounced 32...
分析記事 Mar 25

Here's Why We Think Semler Scientific (NASDAQ:SMLR) Might Deserve Your Attention Today

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...
分析記事 Mar 07

Semler Scientific's (NASDAQ:SMLR) Profits May Not Reveal Underlying Issues

The recent earnings posted by Semler Scientific, Inc. ( NASDAQ:SMLR ) were solid, but the stock didn't move as much as...
分析記事 Mar 04

Semler Scientific, Inc. (NASDAQ:SMLR) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Unfortunately for some shareholders, the Semler Scientific, Inc. ( NASDAQ:SMLR ) share price has dived 25% in the last...
分析記事 Jan 15

Semler Scientific, Inc. (NASDAQ:SMLR) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely

Semler Scientific, Inc. ( NASDAQ:SMLR ) shares have retraced a considerable 26% in the last month, reversing a fair...

業績と収益の成長予測

NasdaqCM:SMLR - アナリストの将来予測と過去の財務データ ( )USD Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/202634-3-3-32
12/31/2025345-1-12
9/30/20253748-27-27N/A
6/30/202543371212N/A
3/31/202549-301717N/A
12/31/202456412424N/A
9/30/202459162221N/A
6/30/202462162020N/A
3/31/202466222626N/A
12/31/202368212121N/A
9/30/202367201719N/A
6/30/202365182022N/A
3/31/202361161417N/A
12/31/202257141517N/A
9/30/202254131617N/A
6/30/202254131617N/A
3/31/202254161213N/A
12/31/202153171516N/A
9/30/202154211920N/A
6/30/202150221516N/A
3/31/202142161516N/A
12/31/202039141415N/A
9/30/202036111213N/A
6/30/202034141314N/A
3/31/202035161315N/A
12/31/201933151113N/A
9/30/201930141011N/A
6/30/2019267N/A8N/A
3/31/2019246N/A7N/A
12/31/2018215N/A5N/A
9/30/2018204N/A3N/A
6/30/2018182N/A2N/A
3/31/2018150N/A1N/A
12/31/201712-2N/A1N/A
9/30/201711-2N/A0N/A
6/30/20179-2N/A0N/A
3/31/20178-2N/A-1N/A
12/31/20167-3N/A-2N/A
9/30/20168-7N/A-4N/A
6/30/20167-8N/A-3N/A
3/31/20167-8N/A-4N/A
12/31/20157-9N/A-4N/A
9/30/20155-5N/A-4N/A
6/30/20154-5N/A-4N/A
3/31/20154-5N/A-4N/A

アナリストによる今後の成長予測

収入対貯蓄率: SMLRの収益は今後 3 年間で減少すると予測されています (年間-187.8% )。

収益対市場: SMLRの収益は今後 3 年間で減少すると予測されています (年間-187.8% )。

高成長収益: SMLRの収益は今後 3 年間で減少すると予測されています。

収益対市場: SMLRの収益は今後 3 年間で減少すると予想されています (年間-5.7% )。

高い収益成長: SMLRの収益は今後 3 年間で減少すると予測されています (年間-5.7% )。


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: SMLRの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です


成長企業の発掘

企業分析と財務データの現状

データ最終更新日(UTC時間)
企業分析2026/01/20 17:01
終値2026/01/15 00:00
収益2025/09/30
年間収益2024/12/31

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
市場価格30年
  • 株価
  • 配当、分割、措置
所有権10年
  • トップ株主
  • インサイダー取引
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
主な進展10年
  • 会社からのお知らせ

* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM(Trailing Twelve Month)またはLTM(Last Twelve Month)データとして知られています。詳細はこちら

分析モデルとスノーフレーク

本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドYoutubeのチュートリアルも掲載しています。

シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

Semler Scientific, Inc. 2 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。3

アナリスト機関
Mark PalmerBenchmark Company
Marc WiesenbergerB. Riley Securities, Inc.
Brett KnoblauchCantor Fitzgerald & Co.